Cancer

BIRC6-targeting as potential therapy for advanced, enzalutamide-resistant prostate cancer

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer

A Meta-Analysis Approach for Characterizing Pan-Cancer Mechanisms of Drug Sensitivity in Cell Lines